FDA Import Refusal 1FX-6617525-8/30002/2 — OM Pharmaceuticals
The FDA refused shipment 1FX-6617525-8/30002/2 from OM Pharmaceuticals (India) on Aug 13, 2026. The refused product falls under Drugs and Biologics — ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Aug 13, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61JDA08 ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC)
- Charges
- 75